Search results
Author(s):
Mohamed Riad Abouzid
,
Ibrahim Kamel
,
Karim Ali
,
et al
Added:
2 months ago
Author(s):
Added:
11 months ago
New York Valves 25 - A substudy of TRISCEND II investigating the effect of transcatheter tricuspid valve replacement (TTVR) on preference-weighted health status showed significant benefits in patients who received TTVR.We are joined by Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, US) to discuss the findings from a substudy of the TRISCEND II trial, which aimed to create an…
View more
Added:
7 months ago
Source:
Radcliffe Cardiology
For patients with severe mitral regurgitation (MR) who are unsuitable for surgery or transcatheter edge-to-edge repair (TEER), therapeutic options are limited. The prospective, single-arm ENCIRCLE trial evaluated the 1-year outcomes of a novel percutaneous transseptal transcatheter mitral valve replacement (TMVR) system in this challenging patient population.¹The SAPIEN M3 system (Edwards…
View more
Added:
3 months ago
Source:
Transcatheter Academy
One-year outcomes from the LANDMARK trial show the Myval transcatheter heart valve (THV) series is noninferior to contemporary THVs for treating symptomatic severe native aortic stenosis.¹ The results demonstrate comparable clinical efficacy and haemodynamic performance at 1 year.MethodologyLANDMARK (NCT04275726) was a prospective, randomised, open-label, noninferiority trial conducted across 31…
View more
Sex Differences in Imaging for Structural Heart Disease
Author(s):
Rowa H Attar
Added:
4 months ago
Review Article
Author(s):
Pier Pasquale Leone
,
Azeem Latib
Added:
8 months ago
Transcatheter Therapies for FMR
Author(s):
Stephanie K Tom
,
Kanika Kalra
,
Emily Perdoncin
,
et al
Added:
1 year ago
Review Article
Author(s):
Brian Bergmark
Added:
2 weeks ago
EuroPCR 2026 – Dr Brian Bergmark (Brigham and Women's Hospital, Boston, MA, US) joins us to discuss findings from the VESALIUS-CV trial, examining the effect of evolocumab in patients who have undergone coronary stenting but have no prior myocardial infarction or stroke.VESALIUS-CV is a double-blind, randomised, placebo-controlled, multicentre phase 3 trial enrolling 12,301 high-cardiovascular…
View more
Author(s):
Marianne Brodmann
Added:
8 months ago
CIRSE Congress 2025 - 24-month results show the Biotronik Dynetic-35 cobalt chromium balloon-expandable stent was safe and effective in iliac arteries.Prof Marianne Brodmann (Medical University of Graz, Graz, AT) joins us to discuss 24-month findings from BIONETIC-I (NCT04830228). The prospective, international, multi-center, single-arm study aimed to investigate the safety and effectiveness of…
View more
TAVR for Aortic Insufficiency
Author(s):
Marwan Amara
,
Yair Feld
Added:
6 months ago
Review Article